Tumor response at 12 weeks and overall best observed response per RECIST 1.1 criteria
| At 12 weeks N=57 | Overall best response N=57 | |
| Complete response, n (%) | 2 (3.5) | 11 (19.3) |
| Partial response, n (%) | 18 (31.6) | 23 (40.4) |
| Objective response rate, % | 35.1 | 59.6 |
| Stable disease, n (%) | 29 (50.9) | 17 (29.8) |
| Progressive disease, n (%) | 5 (8.8) | 3 (5.3) |
| Confirmed progressive disease per iRECIST criteria | 4 (7.0) | 2 (3.5) |
| Pseudoprogression per iRECIST criteria | 1 (1.8) | 1 (1.8) |
| Non-evaluable, n (%) | 3 (5.3) | 3 (5.3) |
| Disease control rate per RECIST1.1/iRECIST, % | 86.0/87.7 | 89.5/91.2 |
RECIST, Response Evaluation Criteria in Solid Tumors.